Kay Castagnoli - Concepedia

Author

Kay Castagnoli

Also Known As

K Castagnoli, K P Castagnoli, K. CASTAGNOLI, K. Castagnoli, K. P. CASTAGNOLI, K. P. Castagnoli, K.P. CASTAGNOLI, K.P. Castagnoli, KAY CASTAGNOLI, Kay Castagnoli

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Virginia Tech University of California, San Francisco Massachusetts General Hospital Marymount University

About

Kay Castagnoli is an author at Virginia Tech specializing in pharmacology, medicine, and neurochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	24	1.9K
2	Natural Sciences	6	6	255
3	Social Sciences	4	4	649
4	Health Sciences	2	2	114
5	Language Studies	1	1	33

Kay Castagnoli

Publications

Citations

H-Index

Page 1

	Year	Citations
Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. Jiang‐Fan Chen, Kui Xu, Jacobus P. Petzer, PubMed Common ConsumptionNeurotransmitterPharmacotherapySocial SciencesMolecular Pharmacology	2001	509
Neuroprotection by Caffeine and A<sub>2A</sub>Adenosine Receptor Inactivation in a Model of Parkinson's Disease Jiang‐Fan Chen, Kui Xu, Jacobus P. Petzer, Journal of Neuroscience	2001	442
The Pharmacokinetics and Pharmacodynamics of Atracurium in Patients with and without Renal Failure Mark R. Fahey, Stephen M. Rupp, Dennis M. Fisher, Anesthesiology Nitrous OxideUrologyAnesthesiaAtracurium AdministrationNormal Renal Function	1984	123
Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Kazuhiro Chiba, Lisa A. Peterson, Kay Castagnoli, PubMed ToxinologyMetabolomic ProfilingOrganic ChemistryMitochondrial Coincubation MixturesRedox Biology	1985	117
8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism Jiang‐Fan Chen, Salome Steyn, Roland G. W. Staal, Journal of Biological Chemistry	2002	116
Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists Jacobus P. Petzer, Salome Steyn, Kay Castagnoli, Bioorganic & Medicinal Chemistry	2003	108
The Pharmacodynamics and Pharmacokinetics of Vecuronium in Patients Anesthetized with Isoflurane with Normal Renal Function or with Renal Failure Daniel P. Lynam, Roy Cronnelly, Kay Castagnoli, Anesthesiology Normal Renal FunctionPharmacotherapyAnesthetic AdministrationClinical ChemistryChronic Kidney Disease	1988	98
The Neuronal Nitric Oxide Synthase Inhibitor 7-Nitroindazole Also Inhibits the Monoamine Oxidase-B-Catalyzed Oxidation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Kay Castagnoli, Sonya L. Palmer, Andrea H. Anderson, Chemical Research in Toxicology Mitochondrial Respiratory ChainNeurodegenerative DiseasesBiochemistryReactive Nitrogen SpecieMedicine	1997	95
Pancuronium and Vecuronium Pharmacokinetics and Pharmacodynamics in Younger and Elderly Adults Stephen M. Rupp, Kay Castagnoli, Dennis M. Fisher, Anesthesiology AgingPharmacological StudyGeriatricsElderly AdultsNeuromuscular Junction Sensitivity	1987	93
The Neuromuscular Blocking Effects and Pharmacokinetics of ORG 9426 and ORG 9616 in the Cat Karin S. Khuenl-Brady, Kay Castagnoli, P. Claver Canfell, Anesthesiology Animal PhysiologyNeuromusculoskeletal DisorderMuscle FunctionMean Elimination Half-lifeNeurophysiology	1990	86

Page 1